Rentschler Biopharma and Ikarovec partner to expedite new gene therapies
Pharmaceutical Technology
JUNE 2, 2023
Rentschler Biopharma has collaborated with Ikarovec for expediting the new gene therapies to treat ophthalmic disease. Under the deal, Rentschler Biopharma’s ATMP facility in Stevenage, UK, will undertake the bioprocess development of adeno-associated virus (AAV) material.
Let's personalize your content